Frontiers in Immunology (2019)
Attributed to:
Blocking vascular permeability by targeting CD148; a novel approach for treating retinopathy
funded by
NERC
Abstract
No abstract provided
Bibliographic Information
Publication URI: https://www.frontiersin.org/articles/10.3389/fimmu.2019.03031/full
Type: Journal Article/Review
Volume: 10
Parent Publication: Syndecan-3 in Inflammation and Angiogenesis